Key Dates
- Board Meeting Date: Thursday, 12th November 2026
- Meeting Location: Registered Office of the company
- Trading Window Closure Period: From Thursday, 1st October 2026 until 48 hours after the announcement of financial results
- Disclosure Date: 5th November 2026
Agenda Items
The Board of Directors will consider the following items:
1. Consideration and approval of Standalone Unaudited Financial Results for the quarter ended 30th September 2026
2. Consideration and approval of making application to stock exchange(s) for the revocation of suspension of trading of equity shares
3. Any other business with the permission of the chair
Financial Impact Note
Financial results for the quarter ended 30th September 2026 are pending board approval. Specific financial figures and impact of trading suspension revocation are not quantified in this disclosure.